0000-0002-0457-2650 About
Dr Jagtar Singh is an experienced clincial researcher with a demonstrated history of oncology research. He graduated from his PhD in Translational Radiation Onciology and Prostate Adenocarcinoma from the Charles Darwin University in 2019. In addition, he has a Master by Research (Head and Neck Cancer), a Masters in Molecular Biology and Biochemistry and a Bachelor of Science from universities in the Australia and India. He is currently a Adjunct Lecturer at the School of Pharamacy and Medical Sciences.
Dr Singh has led and contributed to cancer research, including Head and Neck Squamous Cell Carcinoma, Prostate Adenocarcinoma and Translational Radiation Oncology. His primary focus is observing immune-specific biomarkers of the homeostatically fluctuating immune response before treatment; it would be possible to determine the periodicity of the immune response oscillation and project forward and accurately time-synchronise SBRT to overcome tumour immune tolerance locally and systemically.
In addition, his secondary focus is on determining whether there is a relationship between the molecular biomarkers found in tumour-free surgical margins, prostatic needle-biopsy specimens, blood plasma, or serum of prostate cancer patients and clinical outcomes such as biochemical recurrence, RT-induced toxicity, disease-free survival, and overall survival.
Employment
-
Griffith University Adjunct Lecturer2024 - Present
Education
-
Charles Darwin University PhD2014 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (7)
- Expression of microRNAs following radiation therapy and association with severity of radiotherapy‑induced toxicity among patients with prostate adenocarcinoma: A systematic review and meta‑analysis Save
- Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinoma Save
- Investigation of circulatory cytokines in patients undergoing intensity-modulated radiotherapy (IMRT) for adenocarcinoma of the prostate and association with acute RT-induced toxicity: A prospective clinical study Save
- The risk factors of head and neck cancer and their general patterns in Australia: A descriptive review and update Save
- Trends in incidence of head and neck cancer in the Northern Territory, Australia, between 2007 and 2010 Save
- An australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): Study protocol Save
- Incidence and mortality from mucosal head and neck cancers amongst Australian states and territories: What it means for the northern territory Save